rilpivirine hydrochloride (Edurant) -

rilpivirine hydrochloride (Edurant)
Information type: Drug best practice guidance
Source: Scottish Medicines Consortium
Specialities: Infection and infectious diseases | Paediatric and neonatal medicine
Summary
Rilpivirine is accepted for use within NHS Scotland in combination with other antiretroviral medicinal products, for the treatment of HIV-1 infection in antiretroviral treatment-naïve patients aged 12 to 18 years and older with a viral load ≤ 100,000 HIV-1 RNA copies/mL.
UKMi comment
The Scottish Medicines Consortium has previously accepted rilpivirine in this indication in adult patients.
Related links: